Njar VC - Search Results

1

Aromatase inhibitors in advanced breast cancer: mechanism of action and clinical implications.

Brodie AM, Njar VC. Brodie AM, et al. Among authors: njar vc. J Steroid Biochem Mol Biol. 1998 Jul;66(1-2):1-10. doi: 10.1016/s0960-0760(98)00022-3. J Steroid Biochem Mol Biol. 1998. PMID: 9712406 Review. No abstract available.

2

Novel retinoic acid metabolism blocking agents have potent inhibitory activities on human breast cancer cells and tumour growth.

Patel JB, Mehta J, Belosay A, Sabnis G, Khandelwal A, Brodie AM, Soprano DR, Njar VC. Patel JB, et al. Among authors: njar vc. Br J Cancer. 2007 Apr 23;96(8):1204-15. doi: 10.1038/sj.bjc.6603705. Epub 2007 Mar 27. Br J Cancer. 2007. PMID: 17387344 Free PMC article.

3

Cytochrome p450 retinoic acid 4-hydroxylase inhibitors: potential agents for cancer therapy.

Njar VC. Njar VC. Mini Rev Med Chem. 2002 Jun;2(3):261-9. doi: 10.2174/1389557023406223. Mini Rev Med Chem. 2002. PMID: 12370067 Review.

4

Pharmacokinetic profile of 3beta-hydroxy-17-(1H-1,2,3-triazol-1-yl)androsta-5,16-diene (VN/87-1), a potent androgen synthesis inhibitor, in mice.

Nnane IP, Njar VC, Brodie AA. Nnane IP, et al. Among authors: njar vc. J Steroid Biochem Mol Biol. 2001 Sep;78(3):241-6. doi: 10.1016/s0960-0760(01)00096-6. J Steroid Biochem Mol Biol. 2001. PMID: 11595504

5

Mechanistic studies on aromatase and related C-C bond cleaving P-450 enzymes.

Akhtar M, Njar VC, Wright JN. Akhtar M, et al. Among authors: njar vc. J Steroid Biochem Mol Biol. 1993 Mar;44(4-6):375-87. doi: 10.1016/0960-0760(93)90241-n. J Steroid Biochem Mol Biol. 1993. PMID: 8476751 Review.

6

Pregnenolone stimulates LNCaP prostate cancer cell growth via the mutated androgen receptor.

Grigoryev DN, Long BJ, Njar VC, Brodie AH. Grigoryev DN, et al. Among authors: njar vc. J Steroid Biochem Mol Biol. 2000 Dec 1;75(1):1-10. doi: 10.1016/s0960-0760(00)00131-x. J Steroid Biochem Mol Biol. 2000. PMID: 11179903

7

Potent inhibition of retinoic acid metabolism enzyme(s) by novel azolyl retinoids.

Njar VC, Nnane IP, Brodie AM. Njar VC, et al. Bioorg Med Chem Lett. 2000 Sep 4;10(17):1905-8. doi: 10.1016/s0960-894x(00)00391-7. Bioorg Med Chem Lett. 2000. PMID: 10987414

8

Effects of novel 17-azolyl compounds on androgen synthesis in vitro and in vivo.

Nnane IP, Njar VC, Liu Y, Lu Q, Brodie AM. Nnane IP, et al. Among authors: njar vc. J Steroid Biochem Mol Biol. 1999 Dec 15;71(3-4):145-52. doi: 10.1016/s0960-0760(99)00129-6. J Steroid Biochem Mol Biol. 1999. PMID: 10659703

9

Effects of new 17alpha-hydroxylase/C(17,20)-lyase inhibitors on LNCaP prostate cancer cell growth in vitro and in vivo.

Grigoryev DN, Long BJ, Nnane IP, Njar VC, Liu Y, Brodie AM. Grigoryev DN, et al. Among authors: njar vc. Br J Cancer. 1999 Oct;81(4):622-30. doi: 10.1038/sj.bjc.6690739. Br J Cancer. 1999. PMID: 10574247 Free PMC article.

10

Cytochrome P450c17-expressing Escherichia coli as a first-step screening system for 17alpha-hydroxylase-C17,20-lyase inhibitors.

Grigoryev DN, Kato K, Njar VC, Long BJ, Ling YZ, Wang X, Mohler J, Brodie AM. Grigoryev DN, et al. Among authors: njar vc. Anal Biochem. 1999 Feb 15;267(2):319-30. doi: 10.1006/abio.1998.2993. Anal Biochem. 1999. PMID: 10036137

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results